Skip to content

300759.SZ

Pharmaron Beijing Co., Ltd.

SZSE · Healthcare · M 科研服务 · CN

CNY 44.86
−6.50%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue15.2B14.1B12.3B11.5B10.3B
Cost of Revenue10.1B9.2B8.1B7.4B6.5B
Gross Profit5.1B4.9B4.2B4.1B3.8B
Operating Expenses
R&D Expense609.5M576.0M469.3M448.3M282.3M
SG&A Expense(109.0M)
General & Admin Expense1.3B1.7B1.6B1.6B1.5B
Selling & Marketing Expense188.3M306.5M258.4M252.8M230.1M
Other Expenses675.9M
Total Operating Expenses3.0B2.9B2.6B2.4B2.3B
Cost and Expenses13.1B12.1B10.6B9.8B8.8B
Operating Income (EBIT)2.1B1.9B2.1B1.8B1.7B
Non-Operating
Interest Income10.7M
Interest Expense48.2M
Net Interest Income(37.5M)
Other Non-Op Income/Expense(18.1M)
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)2.0B1.9B2.1B1.8B1.7B
Income Tax Expense411.4M357.5M377.1M256.1M314.3M
Bottom Line
Net Income1.7B1.7B1.8B1.6B1.4B
Earnings from Cont. Ops1.6B1.6B1.7B1.6B1.4B
Earnings from Discont. Ops
Bottom Line Net Income1.7B1.7B1.8B1.6B1.4B
Per Share
Basic EPSCN¥0.96CN¥0.94CN¥1.01CN¥0.90CN¥0.78
Diluted EPSCN¥0.96CN¥0.94CN¥1.01CN¥0.90CN¥0.77
Revenue Per ShareCN¥8.29CN¥8.00CN¥6.94CN¥6.51CN¥5.79
Shares
Basic Shares Outstanding1.8B1.8B1.8B1.8B1.8B
Diluted Shares Outstanding1.8B1.8B1.8B1.8B1.8B
Profitability Metrics
EBITDA889.0M3.0B3.1B2.7B2.3B
D&A359.7M1.1B974.9M822.6M630.6M
EBIT529.4M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026